$2.31B in disclosed funding across 21 BCI companies between January 2025 and September 2026. Covers funding events, valuations, modality and clinical stage, with sources for every company.
INSIDE THE REPORT
Funding per company, split by 2025 and 2026
Valuation stack across the leading companies
Modality, indication and clinical stage for all 21 companies
Sources for every figure
Ready to downloadPDF
Thanks for downloading. The report opens as a PDF.
.svg)